Suche Forschungsprojekt

Suche Forschungsprojekt

Weitere Suchoptionen

76 Ergebnis(se)

Forschungsprojekt(e)

Conformational triggers, Mechanisms and Pathways for Neurodegenerative Disease Trinity College Dublin Institute of Neuroscience

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias Instituto de Biologia Molecular e Celular Centro de Genética Preditiva e Preventiva

Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction. Instituto de Biologia Molecular e Celular Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

Mapping and identification of new disease genes in autosomal dominant spinocerebellar ataxias Instituto de Biologia Molecular e Celular Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias Instituto de Biologia Molecular e Celular Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias Hospital São Sebastião Serviço de Neurologia

Clinical studies, genetic bases and prognostic biomarkers in rare neurodegenerative diseases Centro de Investigación Príncipe Felipe (CIPF) Unidad de Genética y Genómica de Enfermedades Neuromusculares y Neurodegenerativas

Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias Barts and The London School of Medicine and Dentistry Centre for Neuroscience and Trauma

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias PMARC - The University of Edinburgh Perception-Movement-Action Research Consortium

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias School of Informatics, The University of Edinburgh Human Communication Research Centre

The etiology of inherited neurological diseases Phoenix Children's Hospital Barrow Neurological Institute

PolyQure: Ursächliche Behandlung von Polyglutamin-Erkrankungen durch Inhibition von TRMT2A - Hochdurchsatz- und strukturbiologische Verfahren Helmholtz Zentrum München Institut für Strukturbiologie - AG Niessing

CAG102-Knock-In Modell für die Spinocerebelläre Ataxie Typ 2 Neurologische Universitätsklinik Klinik für Neurologie

TreatPolyQ: Allel-spezifische Reduzierung der mutierten Polyglutamin-Proteine zur Behandlung der Huntington-Krankheit, spinozerebellären Ataxie Typ 3 und spinozerebellären Ataxie Typ 7 (Koordinator) Ruhr-Universität Bochum Humangenetik Bochum

Neuro2D3 - Standardisierte Systeme zur Modellierung spät einsetzender neurologischer Erkrankungen und Wirkstoffscreening in 2D und 3D Kulturen Universitätsklinikum Bonn (AöR) Institut für Rekonstruktive Neurobiologie

Study of proliferative and regenerative potential of the photoreceptors in a SCA7 mouse model, a disease by polyglutamine expansion Institut de génétique et de biologie moléculaire et cellulaire - IGBMC Département Médecine translationnelle et neurogénétique

BIOSCA:Biomarkers in Autosomal Dominant Cerebellar Ataxia APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière UF de Neurogénétique Moléculaire et Cellulaire

Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases CHU de Montpellier - IURC Laboratoire de Génétique Moléculaire

A drosophila model to study the neurodegenerative disease Dentatorubral-pallidoluysian atrophy IRCCS Ospedale San Raffaele Divisione di Genetica e Biologia Cellulare - Dipartimento di Genomica Funzionale

Development of therapeutic strategy for DRPLA based on gene silencing and genome editing. Brain Research Institute, Niigata University Department of Neurology

Development of molecular therapy for non-coding repeat diseases targeting unconventional repeat associated non- ATG (RAN) translation Osaka University Graduate School of Medicine Department of Neurotherapeutics

Transgenic monkey model of the polyglutamine diseases recapitulating progressive neurological symptoms: establishing pathological mechanism and effective treatment for spinocerenellar ataxia type 3 National Center of Neurology and Psychiatry Department of Neurophysiology

Developing antisense ol igonucleotide therapy targeting bidirectional transcription underlying an inherited neurodegenerative disease. Tokyo Medical and Dental University Medical Hospital Center for Personalized Medicine for Healthy Aging

Gene therapy against SCA1 based on the molecular pathomechanism Tokyo Medical and Dental University Medical Research Institute Department of Neuropathology

Muscle rehabilitation of cerebral palsy patients recieving botulinum toxin type-A (Botox) treatments University of Calgary Faculty of Kinesiology

Targeting ataxin-1 in spinocerebellar ataxia type 1 (SCA1) patient-specific induced pluripotent stem cell-derived neurons Institution: Information not provided - NL

Does the transplantation of mutant ataxin-3-depleted patient-derived NSC alleviates Machado Joseph disease (MJD)? Institution: Information not provided - PT

Exomes as gene delivery vectors for the treatment of machado-Joseph disease/spinocerebellar ataxia type 3 Institution: Information not provided - PT

Screening of therapeutic compounds in a C. elegans model of Machado-Joseph disease Universidade do Minho Grupo de Neurociências

The role of calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease: a molecular therapy approach with viral vectors. Centro de Neurociências da Universidade de Coimbra Departmento de vectores e terapia génica

Regulation by phosphorylation of ataxin-3, the mutated protein in Machado Joseph Disease Centro de Neurociências da Universidade de Coimbra Glutamatergic Synapses: Formation and regulation of synapses

A peptide aptamer-based approach to neurodegenerative disorders. Instituto de Biologia Molecular e Celular Protein Crystallography Group

CACNA1A gene involvement in cognition and synaptic function in calcium channel disease. Instituto de Biologia Molecular e Celular Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

Search for disease modifiers in spinocerebellar ataxias: human and animal-based approaches. Instituto de Biologia Molecular e Celular Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

The role of an atrophin-brakeless protein complex in gene regulation and neurodegeneration in particularly Stockholm University Department of Molecular Biosciences, The Wenner-Gren Institute (MBW)

Investigation of mechanisms affecting protein aggregation and neuronal toxicity in polyglutamine diseases using spinocerebellar ataxia type 7 (SCA7) as a model system Stockholm University Department of Neurochemistry

Swiss Primary Hypersomnolence and Narcolepsy Cohort Study University Hospital Inselspital Universitätsklinik für Neurologie

TreatPolyQ: Allele-specific lowering of mutant polyQ proteins as treatment for Huntington disease, spinocerebellar ataxia type 3 and spinocerebellar ataxia type 7 - CH Centre Hospitalier Universitaire Vaudois CHUV Laboratoire des neurothérapies et neuromodulation

RAREGenomics: Network of Genomic, Functional, Clinical and Therapeutic Resources for the Study of Rare Neurological Diseases Hospital Universitario Fundación Jiménez Díaz Servicio de Genética Clínica

Natural history of spinocerebellar ataxia type 7 (sca7) Institution: Information not provided - US

Unraveling the mechanisms of motor neuron degeneration if spinocerebellar ataxia; type 1 Institution: Information not provided - US

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR Muséum National d'Histoire Naturelle Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FROGH : FRench Regional Origins in Genetics for Health - FR Institut de Recherche en Santé - Université de Nantes L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

Diverse rare diseases caused by functional dysregulation of Rho GTPase-related proteins ISS - Istituto Superiore di Sanità Centro Nazionale Malattie Rare

Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine Research Institute of Environmental Medicine, Nagoya University

Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability Research Institute of Environmental Medicine, Nagoya University

Formation of integrated omics analysis base of refractory diseases in children and perinatal period National Center for Child Health and Development Research Institute

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer Hospital for Sick Children, Research Institute

Bioinformatics developments based on network and systems biology to identify new candidate genes for rare genetic diseases Fundación Jiménez Díaz Área de Genética y Genómica

A powerful web-based discovery platform for rare disease genetics Institution: Information not provided - US

Multizentrische Forschungsprojekte

EUROSCA: European integrated project on spinocerebellar ataxias (FINISHED) Institut für Medizinische Genetik und angewandte Genomik Tübingen Institut für Medizinische Genetik und angewandte Genomik

SPATAX: European network for hereditary spinocerebellar degenerative disorders Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITASPA: clinical and genetic analysis of spastic paraplegias Fondazione EBRI Istituto di Neurobiologia e Medicina Molecolare

Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases Institut für Medizinische Genetik und angewandte Genomik Tübingen Institut für Medizinische Genetik und angewandte Genomik

PPPT-MJD: towards the understanding of pathological protein processing and toxicity in Machado-Joseph Disease Zentralinstitut für Seelische Gesundheit Abteilung Translationale Hirnforschung

TreatPolyQ: Industrial Academic Initial Training Network (Itn) Towards Treatment Of Polyglutamine Diseases -terminated- Institut für Medizinische Genetik und angewandte Genomik Tübingen Institut für Medizinische Genetik und angewandte Genomik

TreatPolyQ: Allel-spezifische Reduzierung der mutierten Polyglutamin-Proteine zur Behandlung der Huntington-Krankheit, spinozerebellären Ataxie Typ 3 und spinozerebellären Ataxie Typ 7 Ruhr-Universität Bochum Humangenetik Bochum

RISCA: prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SC2, SCA3, SCA6) Universitätsklinikum Bonn (AöR) Klinik und Poliklinik für Neurologie

ESMI: European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative Universitätsklinikum Bonn (AöR) Klinik und Poliklinik für Neurologie

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy Muséum National d'Histoire Naturelle Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FROGH : FRench Regional Origins in Genetics for Health Institut de Recherche en Santé - Université de Nantes L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed) IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO Servizio Clinico di Consulenza Genetica

Maternal Infant Child and Youth Research Network (MICYRN) University of British Columbia Maternal Infant Child and Youth Research Network

CIEN: Spanish Network for Cooperative Research in Neurological diseases Hospital Universitari de Bellvitge Unidad de Neuropatología

DENDRON - north Thames region: Dementias & Neurodegenerative Diseases Research Network Camden Mews Day Hospital North Thames DeNDRoN, Camden & Islington Mental Health Trust

DENDRON - north west region: Dementias & Neurodegenerative Diseases Research Network Wythenshawe Hospital Dementias & Neurodegenerative Diseases Research Network

DENDRON - south coast region: Dementias & Neurodegenerative Diseases Research Network Moorgreen Hospital Memory & Assessment & Research Centre

DENDRON - east Anglia region: Dementias & Neurodegenerative Diseases Research Network Julian Hospital

DENDRON - Thames valley region: Dementias & Neurodegenerative Diseases Research Network Churchill Hospital Fulbrook Centre

DENDRON - south west region: Dementias & Neurodegenerative Diseases Research Network St Martin's Hospital Research Institute for the Care of the Elderly (RICE)

DENDRON - north east region: Dementias & Neurodegenerative Diseases Research Network Newcastle General Hospital Wolfson Research Centre

Alzheimer Europe: European database on rare forms of dementia Alzheimer Europe Office

EUROSPIN: European consortium on synaptic protein networks in Neurological and Psychiatric diseases Max-Planck-Institut für experimentelle Medizin Abteilung Molekulare Neurobiologie

Conformational triggers, Mechanisms and Pathways for Neurodegenerative Disease
Trinity College Dublin

Institute of Neuroscience

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular

Centro de Genética Preditiva e Preventiva

Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular

Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

Mapping and identification of new disease genes in autosomal dominant spinocerebellar ataxias
Instituto de Biologia Molecular e Celular

Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular

Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Hospital São Sebastião

Serviço de Neurologia

Clinical studies, genetic bases and prognostic biomarkers in rare neurodegenerative diseases
Centro de Investigación Príncipe Felipe (CIPF)

Unidad de Genética y Genómica de Enfermedades Neuromusculares y Neurodegenerativas

Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry

Centre for Neuroscience and Trauma

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh

Perception-Movement-Action Research Consortium

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh

Human Communication Research Centre

The etiology of inherited neurological diseases
Phoenix Children's Hospital

Barrow Neurological Institute

PolyQure: Ursächliche Behandlung von Polyglutamin-Erkrankungen durch Inhibition von TRMT2A - Hochdurchsatz- und strukturbiologische Verfahren
Helmholtz Zentrum München

Institut für Strukturbiologie - AG Niessing

CAG102-Knock-In Modell für die Spinocerebelläre Ataxie Typ 2
Neurologische Universitätsklinik

Klinik für Neurologie

TreatPolyQ: Allel-spezifische Reduzierung der mutierten Polyglutamin-Proteine zur Behandlung der Huntington-Krankheit, spinozerebellären Ataxie Typ 3 und spinozerebellären Ataxie Typ 7 (Koordinator)
Ruhr-Universität Bochum

Humangenetik Bochum

Neuro2D3 - Standardisierte Systeme zur Modellierung spät einsetzender neurologischer Erkrankungen und Wirkstoffscreening in 2D und 3D Kulturen
Universitätsklinikum Bonn (AöR)

Institut für Rekonstruktive Neurobiologie

Study of proliferative and regenerative potential of the photoreceptors in a SCA7 mouse model, a disease by polyglutamine expansion
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC

Département Médecine translationnelle et neurogénétique

BIOSCA:Biomarkers in Autosomal Dominant Cerebellar Ataxia
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

UF de Neurogénétique Moléculaire et Cellulaire

Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases
CHU de Montpellier - IURC

Laboratoire de Génétique Moléculaire

A drosophila model to study the neurodegenerative disease Dentatorubral-pallidoluysian atrophy
IRCCS Ospedale San Raffaele

Divisione di Genetica e Biologia Cellulare - Dipartimento di Genomica Funzionale

Development of therapeutic strategy for DRPLA based on gene silencing and genome editing.
Brain Research Institute, Niigata University

Department of Neurology

Development of molecular therapy for non-coding repeat diseases targeting unconventional repeat associated non- ATG (RAN) translation
Osaka University Graduate School of Medicine

Department of Neurotherapeutics

Transgenic monkey model of the polyglutamine diseases recapitulating progressive neurological symptoms: establishing pathological mechanism and effective treatment for spinocerenellar ataxia type 3
National Center of Neurology and Psychiatry

Department of Neurophysiology

Developing antisense ol igonucleotide therapy targeting bidirectional transcription underlying an inherited neurodegenerative disease.
Tokyo Medical and Dental University Medical Hospital

Center for Personalized Medicine for Healthy Aging

Gene therapy against SCA1 based on the molecular pathomechanism
Tokyo Medical and Dental University Medical Research Institute

Department of Neuropathology

Muscle rehabilitation of cerebral palsy patients recieving botulinum toxin type-A (Botox) treatments
University of Calgary

Faculty of Kinesiology

Targeting ataxin-1 in spinocerebellar ataxia type 1 (SCA1) patient-specific induced pluripotent stem cell-derived neurons
Institution: Information not provided - NL

Does the transplantation of mutant ataxin-3-depleted patient-derived NSC alleviates Machado Joseph disease (MJD)?
Institution: Information not provided - PT

Exomes as gene delivery vectors for the treatment of machado-Joseph disease/spinocerebellar ataxia type 3
Institution: Information not provided - PT

Screening of therapeutic compounds in a C. elegans model of Machado-Joseph disease
Universidade do Minho

Grupo de Neurociências

The role of calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease: a molecular therapy approach with viral vectors.
Centro de Neurociências da Universidade de Coimbra

Departmento de vectores e terapia génica

Regulation by phosphorylation of ataxin-3, the mutated protein in Machado Joseph Disease
Centro de Neurociências da Universidade de Coimbra

Glutamatergic Synapses: Formation and regulation of synapses

A peptide aptamer-based approach to neurodegenerative disorders.
Instituto de Biologia Molecular e Celular

Protein Crystallography Group

CACNA1A gene involvement in cognition and synaptic function in calcium channel disease.
Instituto de Biologia Molecular e Celular

Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

Search for disease modifiers in spinocerebellar ataxias: human and animal-based approaches.
Instituto de Biologia Molecular e Celular

Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

The role of an atrophin-brakeless protein complex in gene regulation and neurodegeneration in particularly
Stockholm University

Department of Molecular Biosciences, The Wenner-Gren Institute (MBW)

Investigation of mechanisms affecting protein aggregation and neuronal toxicity in polyglutamine diseases using spinocerebellar ataxia type 7 (SCA7) as a model system
Stockholm University

Department of Neurochemistry

Swiss Primary Hypersomnolence and Narcolepsy Cohort Study
University Hospital Inselspital

Universitätsklinik für Neurologie

TreatPolyQ: Allele-specific lowering of mutant polyQ proteins as treatment for Huntington disease, spinocerebellar ataxia type 3 and spinocerebellar ataxia type 7 - CH
Centre Hospitalier Universitaire Vaudois CHUV

Laboratoire des neurothérapies et neuromodulation

RAREGenomics: Network of Genomic, Functional, Clinical and Therapeutic Resources for the Study of Rare Neurological Diseases
Hospital Universitario Fundación Jiménez Díaz

Servicio de Genética Clínica

Natural history of spinocerebellar ataxia type 7 (sca7)
Institution: Information not provided - US

Unraveling the mechanisms of motor neuron degeneration if spinocerebellar ataxia; type 1
Institution: Information not provided - US

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle

Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes

L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

Diverse rare diseases caused by functional dysregulation of Rho GTPase-related proteins
ISS - Istituto Superiore di Sanità

Centro Nazionale Malattie Rare

Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University

Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University

Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development

Research Institute

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Bioinformatics developments based on network and systems biology to identify new candidate genes for rare genetic diseases
Fundación Jiménez Díaz

Área de Genética y Genómica

A powerful web-based discovery platform for rare disease genetics
Institution: Information not provided - US

EUROSCA: European integrated project on spinocerebellar ataxias (FINISHED)

Institut für Medizinische Genetik und angewandte Genomik Tübingen

Institut für Medizinische Genetik und angewandte Genomik

SPATAX: European network for hereditary spinocerebellar degenerative disorders

Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière

Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITASPA: clinical and genetic analysis of spastic paraplegias

Fondazione EBRI

Istituto di Neurobiologia e Medicina Molecolare

Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases

Institut für Medizinische Genetik und angewandte Genomik Tübingen

Institut für Medizinische Genetik und angewandte Genomik

PPPT-MJD: towards the understanding of pathological protein processing and toxicity in Machado-Joseph Disease

Zentralinstitut für Seelische Gesundheit

Abteilung Translationale Hirnforschung

TreatPolyQ: Industrial Academic Initial Training Network (Itn) Towards Treatment Of Polyglutamine Diseases -terminated-

Institut für Medizinische Genetik und angewandte Genomik Tübingen

Institut für Medizinische Genetik und angewandte Genomik

TreatPolyQ: Allel-spezifische Reduzierung der mutierten Polyglutamin-Proteine zur Behandlung der Huntington-Krankheit, spinozerebellären Ataxie Typ 3 und spinozerebellären Ataxie Typ 7

Ruhr-Universität Bochum

Humangenetik Bochum

RISCA: prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SC2, SCA3, SCA6)

Universitätsklinikum Bonn (AöR)

Klinik und Poliklinik für Neurologie

ESMI: European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative

Universitätsklinikum Bonn (AöR)

Klinik und Poliklinik für Neurologie

STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy

Muséum National d'Histoire Naturelle

Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FROGH : FRench Regional Origins in Genetics for Health

Institut de Recherche en Santé - Université de Nantes

L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed)

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

Servizio Clinico di Consulenza Genetica

Maternal Infant Child and Youth Research Network (MICYRN)

University of British Columbia

Maternal Infant Child and Youth Research Network

CIEN: Spanish Network for Cooperative Research in Neurological diseases

Hospital Universitari de Bellvitge

Unidad de Neuropatología

DENDRON - north Thames region: Dementias & Neurodegenerative Diseases Research Network

Camden Mews Day Hospital

North Thames DeNDRoN, Camden & Islington Mental Health Trust

DENDRON - north west region: Dementias & Neurodegenerative Diseases Research Network

Wythenshawe Hospital

Dementias & Neurodegenerative Diseases Research Network

DENDRON - south coast region: Dementias & Neurodegenerative Diseases Research Network

Moorgreen Hospital

Memory & Assessment & Research Centre

DENDRON - east Anglia region: Dementias & Neurodegenerative Diseases Research Network

Julian Hospital

DENDRON - Thames valley region: Dementias & Neurodegenerative Diseases Research Network

Churchill Hospital

Fulbrook Centre

DENDRON - south west region: Dementias & Neurodegenerative Diseases Research Network

St Martin's Hospital

Research Institute for the Care of the Elderly (RICE)

DENDRON - north east region: Dementias & Neurodegenerative Diseases Research Network

Newcastle General Hospital

Wolfson Research Centre

Alzheimer Europe: European database on rare forms of dementia

Alzheimer Europe Office

EUROSPIN: European consortium on synaptic protein networks in Neurological and Psychiatric diseases

Max-Planck-Institut für experimentelle Medizin

Abteilung Molekulare Neurobiologie